Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Current Cancer Drug Targets
|
December 30, 2014
Novel synthetic pharmacophores inducing a stabilization of cellular microtubules
Anne Martinez, Emmanuelle Soleilhac, Caroline Barette, et al.
Cancers
|
September 14, 2024
Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo
Anne Elisabeth Mercier, Anna Margaretha Joubert, Renaud Prudent, et al.
Leukemia Research
|
December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells
Hanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Chemistry & Biology
|
July 19, 2008
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2
Renaud Prudent, Virginie Moucadel, Béatrice Laudet, et al.
Cancer Chemotherapy and Pharmacology
|
December 31, 2014
Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations
Anne Theron, Renaud Prudent, Elsie Nolte, et al.
ACS Chemical Biology
|
April 10, 2026
An Integrative Biophysical and Computational Workflow Uncovers New Allosteric Sites and Modulators of the Human A<sub>2A</sub> Adenosine Receptor
Renaud Prudent, Arka P Ray, Naveen Thakur, et al.
Cancer Research
|
December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2
Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Journal of Clinical Medicine
|
November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)
Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Scientific Reports
|
November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors
Irina Kufareva, Benoit Bestgen, Paul Brear, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
Miriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Current Cancer Drug Targets
|
December 30, 2014
Novel synthetic pharmacophores inducing a stabilization of cellular microtubules
Anne Martinez, Emmanuelle Soleilhac, Caroline Barette, et al.
Cancers
|
September 14, 2024
Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo
Anne Elisabeth Mercier, Anna Margaretha Joubert, Renaud Prudent, et al.
Leukemia Research
|
December 29, 2020
Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells
Hanane Djamai, Jeannig Berrou, Mélanie Dupont, et al.
Chemistry & Biology
|
July 19, 2008
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2
Renaud Prudent, Virginie Moucadel, Béatrice Laudet, et al.
Cancer Chemotherapy and Pharmacology
|
December 31, 2014
Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations
Anne Theron, Renaud Prudent, Elsie Nolte, et al.
ACS Chemical Biology
|
April 10, 2026
An Integrative Biophysical and Computational Workflow Uncovers New Allosteric Sites and Modulators of the Human A<sub>2A</sub> Adenosine Receptor
Renaud Prudent, Arka P Ray, Naveen Thakur, et al.
Cancer Research
|
December 2, 2010
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2
Renaud Prudent, Virginie Moucadel, Chi-Hung Nguyen, et al.
Journal of Clinical Medicine
|
November 26, 2022
Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)
Jeannig Berrou, Mélanie Dupont, Hanane Djamai, et al.
Scientific Reports
|
November 6, 2019
Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors
Irina Kufareva, Benoit Bestgen, Paul Brear, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 20, 2010
New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
Miriam López-Ramos, Renaud Prudent, Virginie Moucadel, et al.
Page
of 4